Capital Series

The Capital Series is a suite of investments offering diversified exposure to the performance of global markets on a range of asset classes such as equities, currencies, commodities and emerging markets that can often be difficult for investors to directly access.

Suitable for individuals, companies, trusts and SMSFs, each Series offers a combination of the following features:

• A level of capital protection* at maturity
• 100% funding via the Capital Investment Loan
• Diversified exposure to select markets and asset classes
• Capital growth and/or income potential
• No foreign exchange complications as the investment is denominated in Australian dollars
• 3 to 7 year term
• Minimum investments from $10,000
• Close-ended offer periods

Current offers

There are currently no offers

Investor education

• Video 1 – Capital Series overview
• Capital Series PDS Part 1
• Identification Pack

Capital Series update

• Performance update

For more information
Retail investors can call CommSec on 13 15 20 between 8am to 5pm (EST) Monday to Friday or visit www.commsec.com.au.

Wholesale investors and Financial Advisers can call 1300 786 039 from 8am to 6pm (EST), Monday to Friday or email structuredproductsdirect@cba.com.au. 

 

Closed offers

• Capital Series Cornerstone
• Capital Series Protect120
• Capital Series OzAsia
• Capital Series Trio
• Capital Series Compass
• Capital Series Australia II
• Capital Series Australia
• Capital Series Multi Select
• Capital Series Access China
• Capital Series 14 – Equities, Oil, Base Metals and Asian Currencies
• Capital Series 13 – BRICS
• Capital Series 12 – India
• Capital Series 11 – China and Japan
• Capital China 2006
• Capital Europe
• Capital Asia
• Capital Japan

Standard & Poor's Fund Awards 2010

Commonwealth Bank were nominated as a finalist in the newly created structured products category of the Standard and Poor’s (S&P) Fund Awards for 2010.
 

*Capital Protection will generally only apply at the Maturity Date and is subject to risks, limitations and conditions. Please refer to the Product Disclosure Statement for more information. 

^ At maturity, you’ll receive the performance of the S&P/ASX 200 Index, capped at 50% multiplied by the Participation Rate. The Participation Rate is the rate at which you will participate in any return on the Underlying Portfolio. Assuming a minimum Participation Rate of 165%, this gives you a potential for capital growth up to 82.5%. If the Participation Rate is set higher than 165% on the start date, this growth potential increases even further.

• Risk Disclosure
  Commonwealth Bank’s Capital Series products are sophisticated financial products which involve costs and risks such as performance and general investment risk, taxation risks, market risk and other risks. Potential investors should read the Product Disclosure Statement in full before making any investment decision.
  Commonwealth Bank does not guarantee the investment performance of the Capital Series products. 
• Important information
  As this information has been prepared without considering your objectives, financial situation or needs, you should, before acting on this information, consider its appropriateness to your circumstances.
  
  The Capital Series is issued by the Commonwealth Bank of Australia ABN 48 123 123 124 and is administered by its wholly owned but non-guaranteed subsidiary Commonwealth Securities Limited ABN 60 067 254 399 (CommSec), a Participant of the ASX Group. View the relevant Product Disclosure Statement (PDS) provided on this website and consider it before making any decision about that particular product. Investments in Capital Series are not deposits with Commonwealth Bank.  They are contracts entered into between investors and Commonwealth Bank on the terms set out in the Terms of Sale as contained in the PDS.  Investments in the Capital Series involve risks, view the risk sections of the PDS.
  
  Applications for the Capital Investment Loan, Commonwealth Investment Loan and Interest in Advance Loan are subject to Commonwealth Bank's normal credit approval.